Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.985 USD | -0.89% | +0.51% | +17.18% |
May. 31 | Vanda Pharmaceuticals to Commercialize Treatment of Multiple Sclerosis in the US | MT |
May. 27 | Global markets live: UBS, Tesla, Nvidia, Apple, Micron... |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.18% | 293M | |
+16.97% | 123B | |
+13.40% | 107B | |
-6.17% | 24.01B | |
+1.95% | 22.59B | |
-10.09% | 18.16B | |
-40.52% | 16.84B | |
-12.16% | 16.23B | |
+1.57% | 13.43B | |
+21.56% | 11.32B |
- Stock Market
- Equities
- VNDA Stock
- News Vanda Pharmaceuticals Inc.
- Vanda Pharmaceuticals Says Second Phase 3 Study of Tradipitant in Motion Sickness Yields 'Positive' Results